{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:22:23Z","timestamp":1790479343023,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A1B03033721"],"award-info":[{"award-number":["2017R1D1A1B03033721"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203918","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T14:11:00Z","timestamp":1536761460000},"page":"e0203918","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study"],"prefix":"10.1371","volume":"13","author":[{"given":"In Cheol","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooyoung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-4829","authenticated-orcid":true,"given":"Sang Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00228-008-0538-y","article-title":"Proton pump inhibitors: an update of their clinical use and pharmacokinetics","volume":"64","author":"S Shi","year":"2008","journal-title":"European journal of clinical pharmacology"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cgh.2012.11.031","article-title":"Reported side effects and complications of long-term proton pump inhibitor use: dissecting the evidence","volume":"11","author":"DA Johnson","year":"2013","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association","volume":"152","author":"DE Freedberg","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(93)90344-C","article-title":"Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis","volume":"104","author":"R Lamberts","year":"1993","journal-title":"Gastroenterology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0016-5085(90)90946-X","article-title":"Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis","volume":"99","author":"JB Jansen","year":"1990","journal-title":"Gastroenterology"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","article-title":"Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa","volume":"118","author":"EC Klinkenberg-Knol","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/gast.1997.v112.pm9041231","article-title":"Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia","volume":"112","author":"R Eissele","year":"1997","journal-title":"Gastroenterology"},{"issue":"1","key":"ref8","first-page":"R135","article-title":"Identification of gastrin as a growth peptide in human pancreatic cancer","volume":"268","author":"JP Smith","year":"1995","journal-title":"The American journal of physiology"},{"issue":"Suppl 1","key":"ref9","first-page":"S8","article-title":"Hypergastrinemia and gastric enterochromaffin-like cells","volume":"19","author":"C Bordi","year":"1995","journal-title":"The American journal of surgical pathology"},{"issue":"1","key":"ref10","first-page":"R277","article-title":"Identification and characterization of CCK-B\/gastrin receptors in human pancreatic cancer cell lines","volume":"266","author":"JP Smith","year":"1994","journal-title":"The American journal of physiology"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.bjc.6603058","article-title":"Gastrazole (JB95008), a novel CCK2\/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials","volume":"94","author":"I Chau","year":"2006","journal-title":"Br J Cancer"},{"issue":"20","key":"ref12","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1200\/JCO.2002.11.151","article-title":"Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer","volume":"20","author":"BT Brett","year":"2002","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canep.2016.12.006","article-title":"Proton pump inhibitors on pancreatic cancer risk and survival","volume":"46","author":"MD Kearns","year":"2017","journal-title":"Cancer epidemiology"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/bjc.2011.511","article-title":"Proton pump inhibitors and histamine-2-receptor antagonists and pancreatic cancer risk: a nested case-control study","volume":"106","author":"MC Bradley","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"ref15","first-page":"44","article-title":"Use of proton pump inhibitors correlates with increased risk of pancreatic cancer: a case-control study in Taiwan","volume":"46","author":"S-W Lai","year":"2014","journal-title":"Kuwait Med J"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/kwv026","article-title":"Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis","volume":"182","author":"HA Risch","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/heapol\/18.1.84","article-title":"Payment system reform for health care providers in Korea","volume":"18","author":"S Kwon","year":"2003","journal-title":"Health Policy Plan"},{"issue":"1","key":"ref18","first-page":"1857","article-title":"Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients","volume":"11","author":"SH Jeong","year":"2016","journal-title":"International Journal of COPD"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"V Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"issue":"34","key":"ref20","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1200\/JCO.2016.66.4920","article-title":"Prediagnosis Body Mass Index and Risk of Secondary Primary Cancer in Male Cancer Survivors: A Large Cohort Study","volume":"34","author":"SM Park","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"ref21","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs, 2016. Oslo, Norway 2015."},{"issue":"10039","key":"ref22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"T Kamisawa","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/CEJ.0000000000000008","article-title":"Gastrin: from pathophysiology to cancer prevention and treatment","volume":"23","author":"G Maddalo","year":"2014","journal-title":"European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP)"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/j.gastro.2010.08.023","article-title":"Safety of proton pump inhibitor exposure","volume":"139","author":"YX Yang","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cgh.2016.05.018","article-title":"Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis","volume":"14","author":"A Tran-Duy","year":"2016","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4082\/kjfm.2012.33.5.272","article-title":"Use of Proton Pump Inhibitor and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies","volume":"33","author":"JS Ahn","year":"2012","journal-title":"Korean journal of family medicine"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","article-title":"Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy","volume":"8","author":"L Lombardo","year":"2010","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.12304","article-title":"Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth","volume":"37","author":"C Jacobs","year":"2013","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/2050640616630117","article-title":"Systematic review and meta-analysis: Small intestinal bacterial overgrowth in chronic pancreatitis","volume":"4","author":"G Capurso","year":"2016","journal-title":"United European gastroenterology journal"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"LE Levesque","year":"2010","journal-title":"BMJ (Clinical research ed)"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies","volume":"44","author":"P Maisonneuve","year":"2015","journal-title":"International journal of epidemiology"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bpg.2010.02.007","article-title":"Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection","volume":"24","author":"S Raimondi","year":"2010","journal-title":"Best practice & research Clinical gastroenterology"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mdu276","article-title":"Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium","volume":"25","author":"C Bosetti","year":"2014","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","article-title":"Tobacco and the risk of pancreatic cancer: a review and meta-analysis","volume":"393","author":"S Iodice","year":"2008","journal-title":"Langenbeck's archives of surgery"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archinternmed.2010.63","article-title":"Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)","volume":"170","author":"AA Arslan","year":"2010","journal-title":"Archives of internal medicine"},{"issue":"7319","key":"ref36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"S Yachida","year":"2010","journal-title":"Nature"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10552-015-0595-3","article-title":"Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis","volume":"26","author":"A Schulte","year":"2015","journal-title":"Cancer causes & control: CCC"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22123","article-title":"The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease","volume":"120","author":"J Luo","year":"2007","journal-title":"Int J Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T16:41:48Z","timestamp":1540312908000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203918"}},"subtitle":[],"editor":[{"given":"Eric J.","family":"Duell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203918","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]}}}